| Literature DB >> 28578649 |
Alexey Stepanov1, Yakov Lomakin1, Alexander Gabibov1, Alexey Belogurov2.
Abstract
The mammalian immune system is a nearly perfect defensive system polished by a hundred million years of evolution. Unique flexibility and adaptivity have created a virtually impenetrable barrier to numerous exogenous pathogens that are assaulting us every moment. Unfortunately, triggers that remain mostly enigmatic will sometimes persuade the immune system to retarget against self-antigens. This civil war remains underway, showing no mercy and taking no captives, eventually leading to irreversible pathological changes in the human body. Research that has emerged during the last two decades has given us hope that we may have a chance to overcome autoimmune diseases using a variety of techniques to "reset" the immune system. In this report, we summarize recent advances in utilizing short polypeptides - mostly fragments of autoantigens - in the treatment of autoimmune neurodegeneration. Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.org.Entities:
Keywords: Multiple sclerosis; autoantibodies; autoreactive B cellzzm321990elimination; cross-reactivity; immunotoxins; liposomes; specific allergen immunotherapy; tolerance
Mesh:
Substances:
Year: 2017 PMID: 28578649 DOI: 10.2174/0929867324666170605092221
Source DB: PubMed Journal: Curr Med Chem ISSN: 0929-8673 Impact factor: 4.530